OOIR: Observatory of International Research

Papers

(The median citation count of Journal of the American Heart Association is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-10-01 to 2025-10-01.)

Article	Citations
Right Ventricular–Pulmonary Artery Uncoupling and Strain in Acute Heart Failure	155
Relationship Between Azithromycin and Cardiovascular Outcomes in Unvaccinated Patients With COVID‐19 and Preexisting Cardiovascular Disease	148
Protective Effect on Spinal Cord Injury of Prophylactic Cerebrospinal Fluid Drainage in Extensive Aortic Arch Repair for Type A Aortic Dissection: A Retrospective Cohort Study	145
AhR, IRF5, and HO‐1 Expression in Evaluating Carotid Atherosclerotic Plaque Vulnerability: A Pilot Observational Study	141
Aneurysm and Artery Dissection Following the Use of Vascular Endothelial Growth Factor Inhibitor: A Real‐World Analysis Using a Spontaneous Reporting System	132
Discrimination Between Pre‐ and Postcapillary Pulmonary Hypertension Using Platelet RNA	132
Immune Markers, Blood Pressure Severity, and Cardiac Remodeling 1 to 2 Years After Hypertensive Disorders of Pregnancy	129
Subclinical Measures of Peripheral Atherosclerosis and the Risk of New‐Onset Atrial Fibrillation in the General Population: the Rotterdam Study	125
Culprit Lesion Vessel Size and Risk of Reperfusion Injury in ST‐Segment Elevation Myocardial Infarction: A Cardiac Magnetic Resonance Imaging Study	124
Level of Perivascular Inflammation Is Significantly Lower Around the Left Internal Mammary Artery Than Around Native Coronary Arteries	101
Prevalence and Management of Multiple Valvular Heart Disease in Patients Undergoing Transcatheter Aortic Valve Replacement: A Multicenter Study on the Impact of Staged Valvular Interventions on Outcom	100
Unraveling the Complexities for Antiplatelet Strategies Among Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention	99
Diabetes Enters Stage Right: Genetic Association Studies Suggest Diabetes Promotes Pulmonary Hypertension and Right Ventricular Dysfunction	98
Proteomic Correlates and Prognostic Significance of Kidney Injury in Heart Failure With Preserved Ejection Fraction	97
Randomized, Placebo‐Controlled, Triple‐Blind Clinical Trial of Ivabradine for the Prevention of Cardiac Dysfunction During Anthracycline‐Based Cancer Therapy	96
Comparison of Bolus Dosing of Methohexital and Propofol in Elective Direct Current Cardioversion	95
Co‐Occurrence of Social Risk Factors and Associated Outcomes in Patients With Heart Failure	90
Understanding Participant Perspectives Toward the Formation of a Participant Advisory Board Within the Reasons for Geographic and Racial Differences in Stroke Study: A National Qualitative Study	89
Supranormal Ejection Fraction in Heart Failure: Exploring the Heterogeneity of a Distinct Clinical Phenotype	86
Skeletal Muscle Pathology in Pulmonary Arterial Hypertension and Its Contribution to Exercise Intolerance	84
Contemporary Valvular Mechanisms of Aortic Regurgitation in Tricuspid Aortic Valves: Importance in Repair Versus Replacement Strategy	84
Proton Pump Inhibitor Use and Incident Hypertension in Menopausal Women	81
Inpatient‐Onset Versus Outpatient‐Onset ST‐Segment–Elevation Myocardial Infarction in Patients With Percutaneous Coronary Intervention: A National Registry Study	79
Positive Predictive Value of International Classification of Diseases, Ninth Revision, Clinical Modification , and International Classification of Disease	76
Sex Differences in Outcomes After Percutaneous Coronary Intervention or Coronary Artery Bypass Graft for Left Main Disease: From the DELTA Registries	75

Incidence and Risk Factors for Residual Adverse Events Despite Anticoagulation in Atrial Fibrillation: Results From Phase II/III of the GLORIA‐AF Registry	75
Arginine Vasopressin Plays a Role in Microvascular Dysfunction After ST‐Elevation Myocardial Infarction	73
Effects of Ablation Versus Drug Therapy on Quality of Life by Sex in Atrial Fibrillation: Results From the CABANA Trial	72
Day‐to‐Day Blood Pressure Variability and Risk of Incident Chronic Kidney Disease in a General Japanese Population	71
Multi‐Trait Polygenic Risk Score, Nongenetic Determinants, and Cardiovascular Disease Death: A Cohort Study of 14 086 Japanese Individuals	70
Personalized Intervention Strategy Based on a Risk Score Generated From Subcutaneous Insertable Cardiac Monitor: Results From Phase 1 of ALLEVIATE‐HF	70
Incidence of Infective Endocarditis Among Patients With Tetralogy of Fallot	69
Multiethnic Perspectives of Shared Decision‐Making in Hypertension: A Mixed‐Methods Study	69
Left Ventricular Ejection Fraction Change Following Percutaneous Coronary Intervention: Correlates and Association With Prognosis	68
Effect of Intensive Lifestyle Intervention on Cardiovascular Risk Factors: Analysis From the Perspective of Long‐Term Variability	68
Machine Learning for Mortality Prediction in Patients With Heart Failure With Mildly Reduced Ejection Fraction	66
Factors Associated With Enhanced Low‐Density Lipoprotein Cholesterol Lowering With Bempedoic Acid	66
Association Between Pulse Pressure and Structural Brain Changes in Aging: A Systematic Review and Meta‐Analysis of Cross‐Sectional and Longitudinal Studies	64
Rationale and Design of the EPISODE Trial: A Randomized Controlled Trial on the Effect of PCSK9 Inhibitors in Calcific Aortic Valve Stenosis	62
SENP1 Protects Against Pressure Overload‐Induced Cardiac Remodeling and Dysfunction Via Inhibiting STAT3 Signaling	62
Long‐Term Activation of Glucagon‐like peptide‐1 receptor by Dulaglutide Prevents Diabetic Heart Failure and Metabolic Remodeling in Type 2 Diabetes	62
Cross‐Sectional Relationships of Proximal Aortic Stiffness and Left Ventricular Diastolic Function in Adults in the Community	62
Contribution of Conventional Cardiovascular Risk Factors to Brain White Matter Hyperintensities	62
Novel Size‐Based High‐Density Lipoprotein Subspecies and Incident Vascular Events	61
Qualifying Event and Recurrence of Ischemic Stroke in Symptomatic Artery Occlusion: A Post Hoc Analysis of CMOSS	61
Early Alteration of Right Ventricle–Pulmonary Artery Coupling in Experimental Heart Failure With Preserved Ejection Fraction	59
Circling In on Pulmonary Arterial Hypertension: Is It Time to Consider Circular RNA circ_0016070 as a Biomarker and Target for Therapy?	59
Differential Characteristics and Outcomes of Urgent/Emergent Versus Elective Aortic Valve Replacement	58
A New Clinical Prediction Rule for Infective Endocarditis in Emergency Department Patients With Fever: Definition and First Validation of the CREED Score	58
Unveiling Clinical and Genetic Distinctions in Pure‐Apical Versus Distal‐Dominant Apical Hypertrophic Cardiomyopathy	57
Correction to: Randomized Clinical Trial to Evaluate an Atrial Fibrillation Stroke Prevention Shared Decision‐Making Pathway	57
Challenges in Assessing Stroke Incidence in Low‐ and Middle‐Income Countries	57
QRS Fragmentation in Preserved Ejection Fraction Heart Failure: Functional Insights, Pathological Correlates, and Prognosis	56
Ankle‐Brachial Index and Energy Production in People Without Peripheral Artery Disease: The BLSA	56
Use of Thrombus Aspiration for Patients With Acute Coronary Syndrome: Insights From the Nationwide J‐PCI Registry	55
Do Individuals With Inherited Cardiac Diseases Experience Reproductive Decision‐Making Guilt?	54
Operational and Ethical Considerations for a National Adult Congenital Heart Disease Database	53
Government Regulation and Percutaneous Coronary Intervention Volume, Access and Outcomes: Insights From the Washington State Cardiac Care Outcomes Assessment Program	53
Correction to: Comparison of Effectiveness Among Different Sodium‐Glucose Cotransporter‐2 Inhibitors According to Underlying Conditions: A Network Meta‐Analysis of Randomized Controlled Trials	53
Cardiovascular Health Metrics Differ Between Individuals With and Without Cancer	52
Real‐Time Ambulatory ECG Does Not Expedite Care	52
Diagnostic Yield and Clinical Utility of Coronary Angiography Versus Coronary Function Testing in Women With Angina and Nonobstructive Coronary Arteries	51
CanCHD Study of Hematopoietic Cancers in Children With and Without Genetic Syndromes	51
Bench to all Bedsides in Genomics and Precision Medicine	51
Comparison of Centers for Disease Control and Prevention and Hospital‐Based Stroke Mortality Data in Kentucky: The Paul Coverdell National Acute Stroke Program	51
Reduced Capacity of High‐Density Lipoprotein to Acquire Free Cholesterol From Triglyceride‐Rich Lipoproteins Is Associated With Elevated Postprandial Hypertriglyceridemia in Healthy Men	51
Myocardial Infarction Across COVID‐19 Pandemic Phases: Insights From the Veterans Health Affairs System	50
Polypill Eligibility for Patients with Heart Failure With Reduced Ejection Fraction in South India: A Secondary Analysis of a Prospective, Interrupted Time Series Study	50
Invasive Hemodynamic Predictors of Survival in Patients With Mitral Stenosis Secondary to Mitral Annular Calcification	50
Differences in Left Atrial Size and Function and Supraventricular Ectopy Between Black and White Participants in the ARIC Study	50
Correction to: Association of Low‐Density Lipoprotein Cholesterol Levels During Statin Treatment With Cardiovascular and Renal Outcomes in Patients With Moderate Chronic Kidney Disease	50
Clinical Metabolomic Landscape of Cardiovascular Physiology and Disease	49
Myocardial Infarction Is Associated With Increased Stroke Severity, In‐Hospital Mortality, and Complications: Insights From China Stroke Center Alliance Registries	49
The Effect of Adiposity on Cardiovascular Function and Myocardial Fibrosis in Patients With Duchenne Muscular Dystrophy	49
Right Ventricular/Pulmonary Artery Coupling in Patients With Heart Failure With Preserved Ejection Fraction: A Clue for Pulmonary Hypertension?	48

Vascular Smooth Muscle Cell Migration and P70S6K: Key Players in Intimal Hyperplasia Development	48
Clinical Outcomes of Concomitant Coronary Artery Bypass Grafting During Ventricular Septal Myectomy	47
Activation of the High Mobility Group Box 1/Receptor for Advanced Glycation Endproducts /NOD‐like Receptor Family Pyrin Domain‐Containing 3 Axis Under Chronic Intermittent Hypoxia Induction Promotes t	47
Impact of Percutaneous Transluminal Renal Angioplasty on Autonomic Nervous System and Natriuresis in Hypertensive Patients With Renal Artery Stenosis	46
Correction to: Lectin‐Like Oxidized Low‐Density Lipoprotein Receptor 1 Inhibition in Type 2 Diabetes: Phase 1 Results	46
Editors and Editorial Board	46
Correction to: Racial and Ethnic Differences in the Association between Classical Cardiovascular Risk Factors and Common Carotid Intima‐Media Thickness: An Individual Participant Data Meta‐Analysis	46
Interatrial Block Predicts Life‐Threatening Arrhythmias in Dilated Cardiomyopathy	46
Association Between Life's Simple 7 and Biomarkers of Cardiovascular Disease: Aldosterone, Interleukin‐6, C‐Reactive Protein	45
Association Between Maternal Factors in Early Pregnancy and Congenital Heart Defects in Offspring: The Japan Environment and Children's Study	45
Prevalence of Mitral Annulus Disjunction and Mitral Valve Prolapse in Patients With Idiopathic Ventricular Fibrillation	45
Independent and Incremental Value of ECG Markers for Prediction of Cancer Therapy‐Related Cardiac Dysfunction	45
Saliva, Plasma, and Multifluid Metabolomic Signatures of Periodontal Disease, Type 2 Diabetes Progression, and Markers of Glycemia and Dyslipidemia Among Puerto Rican Adults With Overweight and Obesit	45
Risk of Death and Cardiovascular Events in Asian Patients With Atrial Fibrillation and Chronic Obstructive Pulmonary Disease: A Report From the Prospective APHRS Registry	45
Lipoprotein Subclasses Associated With High‐Risk Coronary Atherosclerotic Plaque: Insights From the PROMISE Clinical Trial	45
Metabolic Syndrome and Efficacy of Remote Ischemic Postconditioning in Acute Moderate Ischemic Stroke: A Post Hoc Analysis of the RICAMIS Trial	45
Association of Hypertension With Early‐Onset Cryptogenic Ischemic Stroke by the Presence of Patent Foramen Ovale: A Case–Control Study	45
Analysis of Coronary Arterial Aneurysm Regression in Patients With Kawasaki Disease by Aneurysm Severity: Factors Associated With Regression	44
Neuroprotective Effect of Melatonin in a Neonatal Hypoxia–Ischemia Rat Model Is Regulated by the AMPK/mTOR Pathway	44
Sodium‐Glucose Cotransporter‐2 Inhibitors and Primary Prevention of Atherosclerotic Cardiovascular Disease: A Meta‐Analysis of Randomized Trials and Systematic Review	44
Body Mass Index in Adolescence and Long‐Term Risk of Early Incident Atrial Fibrillation and Subsequent Mortality, Heart Failure, and Ischemic Stroke	44
Contributions of Germline and Somatic Mosaic Genetics to Thoracic Aortic Aneurysms in Nonsyndromic Individuals	43
Long‐Term Risk of Cardiovascular Death in Patients With Mildly Reduced Ejection Fraction After Acute Myocardial Infarction: A Multicenter, Prospective Registry Study	43
Door‐to‐Needle Time for Extracorporeal Cardiopulmonary Resuscitation and Neurological Outcomes in Out‐of‐Hospital Cardiac Arrest: A Nationwide Study	43
Postnatal Deletion of Bmal1 in Cardiomyocyte Promotes Pressure Overload Induced Cardiac Remodeling in Mice	43
Hypertension Severity as Quantified by Hypertension Daily Dose and Blood Pressure With Risk of Stroke in REGARDS	43
Stroke Risk Stratification in Patients With Postoperative Atrial Fibrillation After Coronary Artery Bypass Grafting	43
Race, Interleukin‐6, TMPRSS6 Genotype, and Cardiovascular Disease in Patients With Chronic Kidney Disease	43
Sodium‐Glucose Cotransporter‐2 Inhibitors After Acute Myocardial Infarction in Patients With Type 2 Diabetes: A Population‐Based Investigation	43
Long‐Term Outcomes and Clinical Predictors of Mortality Following Occurrence of Stent Thrombosis	43
Pyruvate Kinase M2 Protects Heart from Pressure Overload‐Induced Heart Failure by Phosphorylating RAC1	42
Treatment With Icosapent Ethyl to Reduce Ischemic Events in Patients With Prior Percutaneous Coronary Intervention: Insights From REDUCE‐IT PCI	42
Heart Failure–Related Death in Subjects With Atrial Fibrillation in the United States, 1999 to 2020	42
Cardiovascular Risk Estimation Is Suboptimal in People With HIV	42
Phenotyping of Elderly Patients With Heart Failure Focused on Noncardiac Conditions: A Latent Class Analysis From a Multicenter Registry of Patients Hospitalized With Heart Failure	42
Impact of Maternal–Fetal Environment on Mortality in Children With Single Ventricle Heart Disease	42
microRNA‐29a Regulates ADAM12 Through Direct Interaction With ADAM12 mRNA and Modulates Postischemic Perfusion Recovery	42
Ultrafast Cooling With Total Liquid Ventilation Mitigates Early Inflammatory Response and Offers Neuroprotection in a Porcine Model of Cardiac Arrest	42
Cardiovascular Complications With Delivery Hospitalizations in Patients With Pulmonary Hypertension: A Nationwide Study From 2011 to 2020	41
Monocyte Chemoattractant Protein‐1, Inflammatory Biomarkers, and Prognosis of Patients With Ischemic Stroke or Transient Ischemic Attack: Fndings From a Nationwide Registry Study	41
Temporal Trends in Racial and Ethnic Disparities in Endovascular Therapy in Acute Ischemic Stroke	41
White Matter Hyperintensities: Complex Predictor of Complex Outcomes	41
Phenotypic Trajectories From Acute to Stable Phase in Heart Failure With Preserved Ejection Fraction: Insights From the PURSUIT‐HFpEF Study	41
Real‐Time Arrhythmia Detection Using Hybrid Convolutional Neural Networks	41
Serial Assessment of Shock Severity in Cardiac Intensive Care Unit Patients	41
Residual Stroke Risk Among Patients With Atrial Fibrillation Prescribed Oral Anticoagulants: A Patient‐Level Meta‐Analysis From COMBINE AF	40
Lipid‐Lowering Therapy and Risk of Hemorrhagic Stroke: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials	40
Coronary Artery Disease Events and Carotid Intima‐Media Thickness in Type 1 Diabetes in the DCCT/EDIC Cohort	40
Burden of Hyperlipidemia, Cardiovascular Mortality, and COVID‐19: A Retrospective‐Cohort Analysis of US Data	40
Comparison of Transvalvular Aortic Mean Gradients Obtained by Intraprocedural Echocardiography and Invasive Measurement in Balloon and Self‐Expanding Transcatheter Valves	40
Sociodemographic and Clinical Characteristics and Self‐Care Behaviors Are Associated With Shared Decision‐Making in Adults With Hypertension	40
Contributions of Women to Cardiovascular Science Over Two Decades: Authorship, Leadership, and Mentorship	40
Omega‐3 Polyunsaturated Fatty Acids Intake and Blood Pressure: A Dose‐Response Meta‐Analysis of Randomized Controlled Trials	39
Left Ventricular Outflow Tract Morphology as a Predictor of Conductance Disturbances Following Transcatheter Aortic Valve Replacement	39
Ross Procedure Versus Mechanical Versus Bioprosthetic Aortic Valve Replacement: A Network Meta‐Analysis	39
Effect of Heart Rate on 1‐Year Outcome for Patients With Acute Ischemic Stroke	39
Racial and Ethnic Disparities in the Medical Management of Poststroke Complications Among Patients With Acute Stroke	39
Discriminative Role of Invasive Left Heart Catheterization in Patients Suspected of Heart Failure With Preserved Ejection Fraction	38
Racial and Ethnic Group Underrepresentation in Studies of Adverse Pregnancy Outcomes and Cardiovascular Risk	38
Ticagrelor Monotherapy or Dual Antiplatelet Therapy After Drug‐Eluting Stent Implantation: Per‐Protocol Analysis of the GLOBAL LEADERS Trial	38
Cerebral Amyloid Angiopathy Is Associated With Emotional Dysregulation, Impulse Dyscontrol, and Apathy	38
Alert‐Triggered Patient Education Versus Nurse Feedback for Nonadministered Venous Thromboembolism Prophylaxis Doses: A Cluster‐Randomized Controlled Trial	38
Body Mass Index, Comorbidities, and Ambulatory Care Visits: The REGARDS Study	38
Temporal Trend in Revascularization for Patients With Ischemic Cardiomyopathy and Multivessel Coronary Artery Disease	37
Association of Physical Activity and Lower Respiratory Tract Infection Outcomes in Patients With Cardiovascular Disease	37
New Classification for the Combined Assessment of the Fractional Excretion of Urea Nitrogen and Estimated Plasma Volume Status in Acute Heart Failure	37
SWAP70 Overexpression Protects Against Pathological Cardiac Hypertrophy in a TAK1‐Dependent Manner	37
Workers’ Activity Profiles Associated With Predicted 10‐Year Cardiovascular Disease Risk	37
Real‐World Disparities in Remote Follow‐Up of Cardiac Implantable Electronic Devices and Impact of the COVID‐19 Pandemic: A Single‐Center Experience	37
Wnt Site Signaling Inhibitor Secreted Frizzled‐Related Protein 3 Protects Mitral Valve Endothelium From Myocardial Infarction–Induced Endothelial‐to‐Mesenchymal Transition	37
Association Between Triglyceride–Glucose Index and Carotid Plaque Stability in Different Glycemic Status: A Single‐Center Retrospective Study	37
Heterogeneity in the Prognosis of Acute Kidney Injury Following Percutaneous Coronary Intervention	36
Influence of the Social Environment on Ideal Cardiovascular Health	36
Validation of the GERAADA Score for Predicting 30‐Day Mortality Rate in Acute Type A Aortic Dissection: A Single‐Center Study in China	36
Consensus‐Based Development of a Pediatric Echocardiography Complexity Score: Design, Rationale, and Results of a Quality Improvement Collaborative	36
Concomitant Hepatorenal Dysfunction and Malnutrition in Valvular Heart Surgery: Long‐Term Prognostic Implications for Death and Heart Failure	36
Transthyretin Cardiac Amyloidosis: Underrecognized in the Underrepresented	36
Effect of Combination Antihypertensive Pills on Blood Pressure Control	36
Transcatheter Aortic Valve Implantation in Elderly Patients With Aortic Valve Stenosis: The Role of Frailty, Malnutrition, and Sarcopenia	36
Within‐Physician Differences in Patient Sharing Between Primary Care Physicians and Cardiologists Who Treat White and Black Patients With Heart Disease	36

Cerebral Small‐Vessel Disease Markers on Magnetic Resonance Imaging as Predictors of Recurrent Vascular Events and Death in Ischemic Stroke: A Systematic Review and Meta‐Analysis	36
Ketone Ester D‐β‐Hydroxybutyrate‐(R)‐1,3 Butanediol Prevents Decline in Cardiac Function in Type 2 Diabetic Mice	35
Effects of Sodium–Glucose Cotransporter 2 Inhibitors on Stage 4 Cardiovascular–Kidney–Metabolic Syndrome: A Propensity Score–Matched Study	35
Vitamin C as a Cardioprotective Agent Against Doxorubicin‐Induced Cardiotoxicity	35
High Self‐Reported Levels of Pain 1 Year After a Myocardial Infarction Are Related to Long‐Term All‐Cause Mortality: A SWEDEHEART Study Including 18 376 Patients	35
Impact of Diabetes and Hypertension on Left Ventricular Structure and Function: The Jackson Heart Study	35
Plasma Levels of Advanced Glycation Endproducts and Risk of Cardiovascular Events: Findings From 2 Prospective Cohorts	35
Real‐World Evidence Linking the Predicting Risk of Cardiovascular Disease Events Risk Score and Coronary Artery Calcium	35
Trends in Short‐, Intermediate‐, and Long‐Term Mortality Following Hospitalization for Myocardial Infarction Among Medicare Beneficiaries, 2008 to 2018	35
Quality of Life and Well‐Being in Adults With Fontan Physiology: Findings From the Australian and New Zealand Fontan Registry Quality of Life Study	35
Impella‐Protected High‐Risk Percutaneous Coronary Intervention in the Elderly: Balancing Feasibility and Necessity	35
Long‐Term Adherence to Modifiable Factors and Incident Cardiovascular Disease Among Women With a History of Gestational Diabetes: A Prospective Cohort Study	35
Sex‐Based Differences in Selected Cardiac Implantable Electronic Device Use: A 10‐Year Statewide Patient Cohort	34
Social Determinants of Cardiovascular Health in US Adolescents: National Health and Nutrition Examination Surveys 1999 to 2014	34
Different Metabolic Phenotypes of Obesity and 2 Decades Risk of Cardio–Renal–Metabolic Multimorbidity: Tehran Lipid and Glucose Study	34
Interventions in Adults With Repaired Coarctation of the Aorta	34
Cardiovascular Risk for Patients With and Without Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder	34
CD1d‐Dependent Natural Killer T Cells Mediate Hypertension and Vascular Injury Through Interleukin‐17A	34
Immigration Status and Sex Differences in Primary Cardiovascular Disease Prevention: A Retrospective Study of 5 Million Adults	34
Circulating Branched Chain Amino Acids and Cardiometabolic Disease	34
Long‐Term Clinical‐Pathologic Results of Enzyme Replacement Therapy in Prehypertrophic Fabry Disease Cardiomyopathy	34
Need for Better and Broader Training in Cardio‐Obstetrics: A National Survey of Cardiologists, Cardiovascular Team Members, and Cardiology Fellows in Training	34
Genetic‐Guided Pharmacotherapy for Coronary Artery Disease: A Systematic and Critical Review of Economic Evaluations	34
Association of Home‐Based Cardiac Rehabilitation With Lower Mortality in Patients With Cardiovascular Disease: Results From the Veterans Health Administration Healthy Heart Program	34
Yield on Reinterpretation of Genetic Variants in Pediatric Cardiomyopathy	34
Comparative Safety and Effectiveness of Sotalol Versus Dronedarone After Catheter Ablation for Atrial Fibrillation	34
Association Between Arousals During Sleep and Hypertension Among Patients With Obstructive Sleep Apnea	33
Association Between Physical Activity Dose and Mental Health Among Stroke Survivors	33
Initial eGFR Changes with SGLT2 Inhibitor in Patients With Type 2 Diabetes and Associations With the Risk of Abnormal Serum Potassium Level	33
Genetic Determinants of Left Atrial Function Are Associated With Stroke	33
Renin‐Angiotensin System Inhibitors in Patients With COVID‐19: A Meta‐Analysis of Randomized Controlled Trials Led by the International Society of Hypertension	33
Inflammatory Role of Milk Fat Globule–Epidermal Growth Factor VIII in Age‐Associated Arterial Remodeling	33
Timing and Adherence Matter for Sodium–Glucose Cotransporter‐2 Inhibitors in Heart Failure	33
Left‐Digit Bias in Serum Creatinine Levels and Contrast Administration: A Nationwide Cohort Study Using a Japanese Percutaneous Coronary Intervention Registry	32
Clopidogrel Versus Aspirin as Chronic Maintenance Antiplatelet Monotherapy in Patients After Percutaneous Coronary Intervention With Chronic Kidney Disease: A Post Hoc Analysis of the HOST‐EXAM Trial	32
Sodium‐Glucose Cotransporter 2 Inhibitors in Patients With Systemic Right Ventricles: Incrementally Building the Evidence Base	32
Inflammatory Markers and Stroke Outcomes: Lessons From Neutrophil Counts and Antiplatelet Therapy	32
Clinical Outcome Prediction Model in Tetralogy of Fallot Without Pulmonary Valve Replacement Using Contraction Fraction From the SCOUT‐TOF Registry	32
Congenital Heart Disease, Atrial Fibrillation, and Ischemic Stroke Risk	32
Association of Cardiologist Clinic Visits With Cardiovascular Primary Prevention Outcomes Among People With HIV From Underrepresented Racial and Ethnic Groups in the Southern United States	32
Cerebrovascular Disease Detected on Preprocedural Computed Tomography in Patients With Severe Aortic Stenosis Undergoing Aortic Valve Replacement	32
Machine Learning Approach to Classify Cardiovascular Disease in Patients With Nonalcoholic Fatty Liver Disease in the UK Biobank Cohort	32
Outcome Prediction After Tetralogy of Fallot Repair: A Prospective Clinical and Cardiovascular Magnetic Resonance Study	31
Correction to: Gelatin Methacryloyl Bioadhesive Improves Survival and Reduces Scar Burden in a Mouse Model of Myocardial Infarction	31
Ninety‐Day Stroke or Transient Ischemic Attack Recurrence in Patients Prescribed Anticoagulation in the Emergency Department With Atrial Fibrillation and a New Transient Ischemic Attack or Minor Strok	31
Creatine Kinase Is Associated With Recurrent Stroke and Functional Outcomes of Ischemic Stroke or Transient Ischemic Attack	31
In Vivo Human Single‐Chain Fragment Variable Phage Display‐Assisted Identification of Galectin‐3 as a New Biomarker of Atherosclerosis	31
Identifying Differences: A Key Step in Precision Cardiovascular Disease Prevention	31
Modulation of Abnormal Vasoconstriction Through 2‐Hydroxyisobutyrylation of Tropomyosin 3 Lys141: Targeting Histone Deacetylase 3 as a Key Approach	31
Association of Differences in Cystatin C‐ and Creatinine‐Based Estimated Glomerular Filtration Rate With Prevalence and Incidence of Stroke	31
Cardiogenic Shock Complicating Takotsubo Syndrome: Sex‐Related Differences	31
Invasive Strategy With Intended Percutaneous Coronary Intervention Versus Conservative Treatment in Older People With ST‐Segment–Elevation Myocardial Infarction: A Meta‐Analysis	31
Correction to: Role of Resilience in the Psychological Recovery of Women With Acute Myocardial Infarction	31
Nonsteroidal Mineralocorticoid Receptor Antagonist Finerenone Improves Diastolic Dysfunction in Preclinical Nondiabetic Chronic Kidney Disease	30
Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With 3‐Vessel Coronary Artery Disease and Diabetes	30
Characteristics Associated With Growth Differentiation Factor 15 in Heart Failure With Preserved Ejection Fraction and the Impact of Pirfenidone	30
Comparative Effectiveness of Early Rhythm Control Versus Rate Control for Cardiovascular Outcomes in Patients With Atrial Fibrillation	30
Inflammation‐Derived and Clinical Indicator‐Based Predictive Model for Ischemic Stroke Recovery	30
Glucagon‐Like Peptide‐1 Receptor Agonists and Risk of Venous Thromboembolism: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials	30
Reduced Fetuin‐A Levels Are Associated With Exercise Intolerance and Predict the Risk of Adverse Outcomes in Patients With Heart Failure: The Role of Cardiac–Hepatic–Peripheral Interaction	30
BubR1 Controls Heart Development by Promoting Expression of Cardiogenesis Regulators	30
Effect of Time Delay on Reperfusion After Tenecteplase in an Extended Time Window: Analysis From the CHABLIS‐T Trials	30
Intracranial Hemorrhage Rate and Lesion Burden in Patients With Familial Cerebral Cavernous Malformation	30
Atrial Fibrillation After Patent Foramen Ovale Closure: Incidence, Pathophysiology, and Management	30
Non‐Hispanic Black and Hispanic Patients Have Worse Outcomes Than White Patients Within Similar Stages of Peripheral Artery Disease	30
Association of Socioeconomic Status With Outcomes and Care Quality in Patients Presenting With Undifferentiated Chest Pain in the Setting of Universal Health Care Coverage	30
Metabolic Factors Mediate the Association Between Serum Uric Acid to Serum Creatinine Ratio and Cardiovascular Disease	30
Impact of Left Ventricular Diastolic Pressure Changes on Clinical Outcomes After Transcatheter Aortic Valve Replacement	30
Was COVID‐19 Associated With Worsening Inequities in Stroke Treatment and Outcomes?	30
Renal Denervation Improves Uremic Cardiomyopathy in Rats With Chronic Kidney Disease	30
Coronary Microvascular Disease Assessed by 82‐Rubidium Positron Emission Tomography Myocardial Perfusion Imaging Is Associated With Small Vessel Disease of the Kidney and Brain	30
Obese Male Mice Exposed to Early Life Stress Display Sympathetic Activation and Hypertension Independent of Circulating Angiotensin II	30
Reducing Morbidity and Mortality in Patients With Coarctation Requires Systematic Differentiation of Impacts of Mixed Valvular Disease on Coarctation Hemodynamics	30
Angiographic Microvascular Resistance Is an Independent Predictor of Adverse Clinical Outcomes After Transcatheter Aortic Valve Replacement	30
Translational Research of the Acute Effects of Negative Emotions on Vascular Endothelial Health: Findings From a Randomized Controlled Study	29
Viral Infection and Ischemic Stroke: Emerging Trends and Mechanistic Insights	29
Prediction of Deterioration of Left Ventricular Function Using 3‐Dimensional Speckle‐Tracking Echocardiography in Patients With Left Bundle‐Branch Block	29
Age‐Dependent Relationship of Hypertension Subtypes With Incident Heart Failure	29
Macrophage Ferroptotic Resistance Is Required for the Progression of Infantile Hemangioma	29
County Incarceration Rate and Stroke Death: A Cross‐Sectional Study of the Influence of Physical Environment, Health Care Access, and Community Mental Distress	29
Microvolt QRS Alternans in Hypertrophic Cardiomyopathy: A Novel Risk Marker of Late Ventricular Arrhythmias	29
When the Price Is Right: Beyond the Medical Risks and Benefits of Costly Therapies	29
Plasma Extracellular MicroRNAs Associated With Cardiovascular Disease Risk Factors in Middle‐Aged and Older Adults	29
Hypoxia Attenuates Pressure Overload‐Induced Heart Failure	29
Symmetric Dimethylarginine Predicts Previously Undetected Atrial Fibrillation in Patients With Ischemic Stroke	29
Prospective Observational Study for the Comparison of Screening Methods Including Tongue Pressure and Repetitive Saliva Swallowing With Detailed Videofluoroscopic Swallowing Study Findings in Patients	29
Characterization of “ICU‐30”: A Binary Composite Outcome for Neonates With Critical Congenital Heart Disease	29
Using the Zwolle Risk Score at Time of Coronary Angiography to Triage Patients With ST‐Elevation Myocardial Infarction Following Primary Percutaneous Coronary Intervention or Thrombolysis	29
Differential Expression Analyses on Human Aortic Tissue Reveal Novel Genes and Pathways Associated With Abdominal Aortic Aneurysm Onset and Progression	29
Atrial Structural Remodeling in Patients With Atrial Fibrillation Is a Diffuse Fibrotic Process: Evidence From High‐Density Voltage Mapping and Atrial Biopsy	29
Inflammatory Markers and Measures of Cardiovascular Autonomic Neuropathy in Type 1 Diabetes	29
Relative Cerebral Blood Flow as an Indirect Imaging Surrogate in Patients With Anterior Circulation Large Vessel Occlusion and Association of Baseline Characteristics With Poor Collateral Status	29
Therapeutic Management of Anomalous Coronary Arteries Originating From the Opposite Sinus of Valsalva: Current Evidence, Proposed Approach, and the Unknowing	29
Correction to: Addressing Social Determinants of Health and Mitigating Health Disparities Across the Lifespan in Congenital Heart Disease: A Scientific Statement From the American Heart Association	29
Implication of Different ECG Left Ventricular Hypertrophy in Patients Undergoing Transcatheter Aortic Valve Replacement	29